Literature DB >> 482164

On the central antiserotonin action of trazodone.

L Baran, J Maj, Z Rogóz, G Skuza.   

Abstract

Trazodone, an antidepressant drug with an unknown mechanism of action, has been examined in order to demonstrate its central antiserotonin action. Trazodone antagonizes the head twitch response induced by 5-hydroxytryptophan in rats and mice, or by-5-methoxytryptamine in rats (the ED50 values are 9.3, 5.2, and 10.8 mg/kg respectively). It counteracts convulsions induced by tryptamine in rats (ED50=3.75 mg/kg). Trazodone abolishes hyperthermia induced by serotoninomimetics (LSD, quipazine, fenfluramine) in rabbits. It does not affect ptosis induced by reserpine, and diminishes stimulation of the locomotor activity induced by amphetamine. Our findings demonstrate that trazodone has a central antiserotonin action, similarly as three other antidepressant drugs: mianserin, danitracen and doxepin, whose central antiserotonin action has been found previously.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 482164

Source DB:  PubMed          Journal:  Pol J Pharmacol Pharm        ISSN: 0301-0244


  5 in total

1.  Trazodone, a central serotonin antagonist and agonist.

Authors:  J Maj; W Palider
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

2.  Effects of trazodone treatment on alpha-2 adrenoceptor function in depressed patients.

Authors:  L H Price; D S Charney; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Central action of ipsapirone, a new anxiolytic drug, on serotoninergic, noradrenergic and dopaminergic functions.

Authors:  J Maj; E Chojnacka-Wójcik; E Tatarczyńska; A Kłodzińska
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

4.  The effect of etoperidone, a new potential antidepressant drug, on the central serotonin system.

Authors:  E Przegaliński; A Lewandowska
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

Review 5.  Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-06       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.